Literature DB >> 24398937

Pyroptotic neuronal cell death mediated by the AIM2 inflammasome.

Stephanie E Adamczak1, Juan Pablo de Rivero Vaccari2, Gordon Dale1, Frank J Brand1, Doris Nonner1, M Ross Bullock2, Gerhard P Dahl1, W Dalton Dietrich2, Robert W Keane1.   

Abstract

The central nervous system (CNS) is an active participant in the innate immune response to infection and injury. In these studies, we show embryonic cortical neurons express a functional, deoxyribonucleic acid (DNA)-responsive, absent in melanoma 2 (AIM2) inflammasome that activates caspase-1. Neurons undergo pyroptosis, a proinflammatory cell death mechanism characterized by the following: (a) oligomerization of apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC); (b) caspase-1 dependency; (c) formation of discrete pores in the plasma membrane; and (d) release of the inflammatory cytokine interleukin-1β (IL-1β). Probenecid and Brilliant Blue FCF, inhibitors of the pannexin1 channel, prevent AIM2 inflammasome-mediated cell death, identifying pannexin1 as a cell death effector during pyroptosis and probenecid as a novel pyroptosis inhibitor. Furthermore, we show activation of the AIM2 inflammasome in neurons by cerebrospinal fluid (CSF) from traumatic brain injury (TBI) patients and oligomerization of ASC. These findings suggest neuronal pyroptosis is an important cell death mechanism during CNS infection and injury that may be attenuated by probenecid.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24398937      PMCID: PMC3982080          DOI: 10.1038/jcbfm.2013.236

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  40 in total

1.  Activation of CPP32 during apoptosis of neurons and astrocytes.

Authors:  R W Keane; A Srinivasan; L M Foster; M P Testa; T Ord; D Nonner; H G Wang; J C Reed; D E Bredesen; C Kayalar
Journal:  J Neurosci Res       Date:  1997-04-15       Impact factor: 4.164

2.  AIM2 joins the gang of microbial sensors.

Authors:  Luigi Franchi; Gabriel Nuñez
Journal:  Cell Host Microbe       Date:  2010-05-20       Impact factor: 21.023

3.  Activation of pannexin 1 channels by ATP through P2Y receptors and by cytoplasmic calcium.

Authors:  Silviu Locovei; Junjie Wang; Gerhard Dahl
Journal:  FEBS Lett       Date:  2005-12-12       Impact factor: 4.124

4.  Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol.

Authors:  M K Reinders; E N van Roon; T L Th A Jansen; J Delsing; E N Griep; M Hoekstra; M A F J van de Laar; J R B J Brouwers
Journal:  Ann Rheum Dis       Date:  2008-02-04       Impact factor: 19.103

5.  First report of successful treatment of multidrug-resistant cytomegalovirus disease with the novel anti-CMV compound AIC246.

Authors:  D R Kaul; S Stoelben; E Cober; T Ojo; E Sandusky; P Lischka; H Zimmermann; H Rubsamen-Schaeff
Journal:  Am J Transplant       Date:  2011-05       Impact factor: 8.086

6.  Serum factor supporting long-term survival of rat central neurons in culture.

Authors:  L M Kaufman; J N Barrett
Journal:  Science       Date:  1983-06-24       Impact factor: 47.728

7.  Involvement of the AIM2, NLRC4, and NLRP3 inflammasomes in caspase-1 activation by Listeria monocytogenes.

Authors:  Jianghong Wu; Teresa Fernandes-Alnemri; Emad S Alnemri
Journal:  J Clin Immunol       Date:  2010-05-20       Impact factor: 8.317

8.  The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses.

Authors:  Vijay A K Rathinam; Zhaozhao Jiang; Stephen N Waggoner; Shruti Sharma; Leah E Cole; Lisa Waggoner; Sivapriya Kailasan Vanaja; Brian G Monks; Sandhya Ganesan; Eicke Latz; Veit Hornung; Stefanie N Vogel; Eva Szomolanyi-Tsuda; Katherine A Fitzgerald
Journal:  Nat Immunol       Date:  2010-03-28       Impact factor: 25.606

9.  Therapeutic neutralization of the NLRP1 inflammasome reduces the innate immune response and improves histopathology after traumatic brain injury.

Authors:  Juan Pablo de Rivero Vaccari; George Lotocki; Ofelia F Alonso; Helen M Bramlett; W Dalton Dietrich; Robert W Keane
Journal:  J Cereb Blood Flow Metab       Date:  2009-04-29       Impact factor: 6.200

10.  Cloning a novel member of the human interferon-inducible gene family associated with control of tumorigenicity in a model of human melanoma.

Authors:  K L DeYoung; M E Ray; Y A Su; S L Anzick; R W Johnstone; J A Trapani; P S Meltzer; J M Trent
Journal:  Oncogene       Date:  1997-07-24       Impact factor: 9.867

View more
  104 in total

Review 1.  AIM2 inflammasome in infection, cancer, and autoimmunity: Role in DNA sensing, inflammation, and innate immunity.

Authors:  Si Ming Man; Rajendra Karki; Thirumala-Devi Kanneganti
Journal:  Eur J Immunol       Date:  2015-12-28       Impact factor: 5.532

Review 2.  Long-Term Consequences of Traumatic Brain Injury: Current Status of Potential Mechanisms of Injury and Neurological Outcomes.

Authors:  Helen M Bramlett; W Dalton Dietrich
Journal:  J Neurotrauma       Date:  2014-12-19       Impact factor: 5.269

Review 3.  AIM2 in health and disease: Inflammasome and beyond.

Authors:  Puja Kumari; Ashley J Russo; Sonia Shivcharan; Vijay A Rathinam
Journal:  Immunol Rev       Date:  2020-07-26       Impact factor: 12.988

Review 4.  The far-reaching scope of neuroinflammation after traumatic brain injury.

Authors:  Dennis W Simon; Mandy J McGeachy; Hülya Bayır; Robert S B Clark; David J Loane; Patrick M Kochanek
Journal:  Nat Rev Neurol       Date:  2017-02-10       Impact factor: 42.937

Review 5.  The Possibility and Molecular Mechanisms of Cell Pyroptosis After Cerebral Ischemia.

Authors:  Zhaofei Dong; Kuang Pan; Jingrui Pan; Qingxia Peng; Yidong Wang
Journal:  Neurosci Bull       Date:  2018-10-10       Impact factor: 5.203

Review 6.  NLR proteins and parasitic disease.

Authors:  Gwendolyn M Clay; Fayyaz S Sutterwala; Mary E Wilson
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

Review 7.  Role of AIM2 inflammasome in inflammatory diseases, cancer and infection.

Authors:  Bhesh Raj Sharma; Rajendra Karki; Thirumala-Devi Kanneganti
Journal:  Eur J Immunol       Date:  2019-08-14       Impact factor: 5.532

8.  An association between mitochondria and microglia effector function. What do we think we know?

Authors:  G Jean Harry; Gabrielle Childers; Sahana Giridharan; Irisyunuel Lopez Hernandes
Journal:  Neuroimmunol Neuroinflamm       Date:  2020-06-16

9.  Pannexin1 as a novel cerebral target in pathogenesis of hepatic encephalopathy.

Authors:  Papia Mondal; Surendra Kumar Trigun
Journal:  Metab Brain Dis       Date:  2014-05-08       Impact factor: 3.584

Review 10.  Innate immune activation in neurodegenerative disease.

Authors:  Michael T Heneka; Markus P Kummer; Eicke Latz
Journal:  Nat Rev Immunol       Date:  2014-07       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.